ST
TARO

Spot Trading’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Spot Trading’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-100
Closed -$14K – 4341
2015
Q2 		$14K Buy
+100
New +$14.3K ﹤0.01% 3518

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spot Trading's TARO Position: Q3 2015 in Review

Spot Trading sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2015, closing a stake of 100 shares — an estimated $14K sold.

Spot Trading first reported a position in TARO in Q2 2015 and held it in 1 quarter. The position peaked at $14K in Q2 2015. 121 funds tracked by Wall St. Rank hold TARO as of Q3 2015.

  • Spot Trading reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2015 after selling out during the quarter.
  • Spot Trading sold 100 Taro Pharmaceutical Industries Ltd. shares in Q3 2015, an estimated $14K.
  • Spot Trading first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2015 and held it in 1 quarter.
  • Spot Trading's Taro Pharmaceutical Industries Ltd. position peaked at $14K in Q2 2015.
  • 121 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2015.

Based on Spot Trading's 13F filing for Q3 2015, filed 3 Nov 2015.